MedicineNet study review Nonetheless some sources continue to supply the drug claiming it is effective.
nih.gov
ncbi.nlm.nih.gov
Matsumoto K, Yoshida M, Andersson K, Hedlund P (2005). «Effects in vitro and in vivo by apomorphine in the rat corpus cavernosum.». Br J Pharmacol. 146 2 ed. pp. 259–67. PMID 16025145 !CS1 manut: Nomes múltiplos: lista de autores (link)
Schwab R, Amador L, Lettvin J. «Apomorphine in Parkinson's disease.». Trans Am Neurol Assoc. 56. pp. 251–3. PMID 14913646 !CS1 manut: Nomes múltiplos: lista de autores (link)
Cotzias G, Papavasiliou P, Fehling C, Kaufman B, Mena I (1970). «Similarities between neurologic effects of L-dopa and of apomorphine.». N Engl J Med. 282 1 ed. pp. 31–3. PMID 4901383 !CS1 manut: Nomes múltiplos: lista de autores (link)
Corsini G, Del Zompo M, Gessa G, Mangoni A (1979). «Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease.». Lancet. 1 8123 ed. pp. 954–6. PMID 87620 !CS1 manut: Nomes múltiplos: lista de autores (link)